What is a "mini-tender" offer?

A mini-tender offer is an offer to purchase a small percentage of a company's outstanding shares at a price below the current market value. These offers are often made by third parties and can be confusing for shareholders, sometimes leading them to tender shares at a loss.

Why is MetLife warning shareholders about this offer?

MetLife is warning shareholders because the offer price is significantly lower than the current market price, and the company does not endorse the offer or its terms. They want to protect their shareholders from potentially making a decision that is not in their best financial interest.

What should I do if I received this offer?

MetLife recommends that shareholders do not tender their shares in response to this unsolicited offer. If you have already tendered your shares, you have the right to withdraw them before the offer expires. Review the tender offer documents provided by Potemkin Limited for specific withdrawal instructions and the offer expiration date.

How much of MetLife's stock is being targeted?

The offer is for a maximum of 10,000 shares, which represents approximately 0.00002% of MetLife's outstanding common stock as of August 31, 2025. This is an extremely small portion of the company's total shares.

METLIFE INC 8-K SEC Disclosure

Summary

MetLife, Inc. (MET) has filed an 8-K to disclose receipt of an unsolicited "mini-tender" offer from Potemkin Limited to purchase up to 10,000 shares of common stock at $53.00 per share. This offer price represents a significant discount of approximately 34.42% compared to the recent closing price of $80.82 on September 12, 2025. MetLife, Inc. explicitly states that it does not endorse this offer and is not affiliated with Potemkin Limited. The company is actively advising its shareholders to reject the offer and not tender their shares. The shares targeted by this offer represent a minuscule fraction of the company's outstanding stock, underscoring the limited impact this specific offer is likely to have on the overall shareholder base. Investors should exercise caution and carefully review the terms of any unsolicited offer.

Key Highlights

1MetLife received an unsolicited mini-tender offer from Potemkin Limited for up to 10,000 shares of common stock.
2The offer price of $53.00 per share is substantially below the recent market price of $80.82.
3MetLife does not endorse the mini-tender offer and is not associated with Potemkin Limited.
4The company has issued a press release recommending that shareholders reject the offer.
5The shares targeted represent a very small percentage (0.00002%) of MetLife's outstanding common stock.
6Shareholders who have already tendered shares can withdraw them before the offer expires on October 7, 2025.

METLIFE INC 8-K Report, Corporate Update (Sep 15, 2025)

Summary

Key Highlights

Frequently Asked Questions